Other languages Jiangsu Nhwa Pharmaceutical Co., LTD

Equities

002262

CNE100000CG8

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 29/04/2024 BST			5-day change	1st Jan Change
25.01 ^CNY	-0.28%		+7.39%	-7.78%

04-19	Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-03	Nhwa Pharma Gets Nod to Test NH103 Oxalate Tablets	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jiangsu Nhwa Pharmaceutical Co., LTD Approves Cash Dividend for 2023	04-24
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19
Nhwa Pharma Gets Nod to Test NH103 Oxalate Tablets	04-03
Jiangsu Nhwa Pharmaceutical Co., Ltd Proposes Profit Distribution for 2023	04-01
Nhwa Pharmaceutical's 2023 Profit Climbs 15% as Revenue Rises 17%	04-01
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	03-29
Exchange-Traded Funds Higher, Equity Futures Lower Pre-Bell Monday Ahead of Data-Packed Week	02-26
Teva Pharmaceutical Investments Singapore Pte Ltd. and Jiangsu Nhwa Pharmaceutical Co., LTD Forge Strategic Partnership to Promote Patient Access to Austedo® in China	02-26
Nhwa Pharmaceutical Gets Green Light from US FDA After Addressing API Deficiencies	12-21
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Jiangsu Nhwa Pharma’s H1 Profit Jumps 21.7% as Revenue Rises 20%	31/07/23
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	30/07/23
Wang Zeyu cancelled the acquisition of 13% stake in Jiangsu Farever Pharma Co., Ltd. from Jiangsu Nhwa Pharmaceutical Co., LTD.	27/07/23
Expected House Vote on Debt Ceiling Deal Weighs on Sentiment, Pushing US Equity Futures Lower	31/05/23
Trevena Receives $3 Million Milestone Payment From Partner Jiangsu Nhwa Pharmaceutical	31/05/23
Top Premarket Gainers	31/05/23
Jiangsu Nhwa Pharmaceutical Co., Ltd. Receives Formal Approval from the National Medical Products Administration for OLINVYK	08/05/23
Jiangsu Nhwa Pharmaceutical Co., Ltd Approves Cash Dividend for 2022, Payable on 28 April 2023	17/04/23
Jiangsu Nhwa Pharma’s Q1 Profit Jumps 20.5% as Revenue Rises 19%; Shares Jump 5%	14/04/23
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	13/04/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Jiangsu Nhwa Pharmaceutical Co., LTD

Equities

002262

CNE100000CG8

Other languages

Filters